Cited by 63Liver Disease Diagnosis and TreatmentLipid metabolism and biosynthesisLipid metabolism and disorders

Glycerol-3-Phosphate Acyltransferase 1 Deficiency in ob/ob Mice Diminishes Hepatic Steatosis but Does Not Protect Against Insulin Resistance or Obesity

Open access
Wendel, Angela A., Li, Lei O., Li, Yue, Cline, Gary W., Shulman, Gerald I., Coleman, Rosalind A.·2010·Diabetes

Abstract

OBJECTIVE: Hepatic steatosis is strongly associated with insulin resistance, but a causal role has not been established. In ob/ob mice, sterol regulatory element binding protein 1 (SREBP1) mediates the induction of steatosis by upregulating target genes, including glycerol-3-phosphate acyltransferase-1 (Gpat1), which catalyzes the first and committed step in the pathway of glycerolipid synthesis. We asked whether ob/ob mice lacking Gpat1 would have reduced hepatic steatosis and improved insulin sensitivity. RESEARCH DESIGN AND METHODS: Hepatic lipids, insulin sensitivity, and hepatic insulin signaling were compared in lean (Lep+/?), lean-Gpat1−/−, ob/ob (Lepob/ob), and ob/ob-Gpat1−/− mice. RESULTS: Compared with ob/ob mice, the lack of Gpat1 in ob/ob mice reduced hepatic triacylglycerol (TAG) and diacylglycerol (DAG) content 59 and 74%, respectively, but increased acyl-CoA levels. Despite the reduction in hepatic lipids, fasting glucose and insulin concentrations did not improve, and insulin tolerance remained impaired. In both ob/ob and ob/ob-Gpat1−/− mice, insulin resistance was accompanied by elevated hepatic protein kinase C-ε activation and blunted insulin-stimulated Akt activation. CONCLUSIONS: These results suggest that decreasing hepatic steatosis alone does not improve insulin resistance, and that factors other than increased hepatic DAG and TAG contribute to hepatic insulin resistance in this genetically obese model. They also show that the SREBP1-mediated induction of hepatic steatosis in ob/ob mice requires Gpat1.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db09-1380

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wendel, A. A., Li, L. O., Li, Y., Cline, G. W., Shulman, G. I., & Coleman, R. A.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • Yale University (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
Coleman, Rosalind A.
Venue
Diabetes
Published
2010-03-03
Volume
59
Issue
6
Pages
1321-1329
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2140282855
Cited by
63
References
52
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 7 · 2013: 3 · 2012: 7
FWCI
4.67
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • American Heart Association
  • National Institutes of Health (P30 DK, DK-34987)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK56350, DK40936, U24DK59635, DK-056598, R01DK040936, U24DK059635, R56DK056598, R01DK056598, DK-007129, P30‐DK34987, T32DK007129, P30DK034987, P30DK056350)
  • National Institute of Environmental Health Sciences (P30ES010126)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
GPAT1, hepatic steatosis, insulin resistance, ob/ob mice, SREBP1, glycerolipid biosynthesis, triglycerides, diacylglycerol, acyl-CoA, protein kinase C epsilon, Akt signaling, hepatic insulin signaling, obesity
MeSH terms
Animals, Crosses, Genetic, Fatty Liver, Glycerol-3-Phosphate O-Acyltransferase, Heterozygote, Humans, Insulin Resistance, Lipids, Mice, Obese, Obesity, RNA, Messenger, Triglycerides, Up-Regulation, Muscle, Skeletal, Reverse Transcriptase Polymerase Chain Reaction, Leptin, Mice, Sterol Regulatory Element Binding Protein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review